CMG Pharmaceutical Co., Ltd.
058820.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
74
Cost of Revenue
40
Gross Profit
34
Gross Margin
46.1%
Operating Income
1
Operating Margin
1.0%
Net Income
2
Net Margin
2.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
7
EBITDA Margin
8.8%
2023
12/31/2023
Revenue
70
Cost of Revenue
38
Gross Profit
33
Gross Margin
46.5%
Operating Income
4
Operating Margin
6.1%
Net Income
5
Net Margin
6.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
4
EBITDA Margin
6.0%
2022
12/31/2022
Revenue
62
Cost of Revenue
31
Gross Profit
31
Gross Margin
49.8%
Operating Income
2
Operating Margin
3.6%
Net Income
-0
Net Margin
-0.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
4
EBITDA Margin
6.4%
2021
12/31/2021
Revenue
52
Cost of Revenue
27
Gross Profit
25
Gross Margin
48.1%
Operating Income
1
Operating Margin
2.4%
Net Income
2
Net Margin
4.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1
EBITDA Margin
1.6%
2020
12/31/2020
Revenue
48
Cost of Revenue
25
Gross Profit
23
Gross Margin
48.4%
Operating Income
1
Operating Margin
2.8%
Net Income
0
Net Margin
0.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
2
EBITDA Margin
4.7%